| 摘要 |
Novel compounds of Formula I <FORM:1036395/C2/1> where R represents a phenyl radical which may be substituted by low alkyl, alkoxy, alkylthio, alkylsuphonyl, alkylamino, dialkylamino, alkanoylamino, alkylsulphamoyl, dialkylsulphamoyl, hydroxyl, nitro, amino, sulphamoyl or trifluoromethyl groups, and/or by halogen atoms, or the 2-thienyl radical, A is an ethylene or trimethylene radical which may be substituted by alkyl and/or phenyl radicals, and B represents an alkylene radical having 2-7 carbon atoms, and having 2 or 3 carbon atoms between the valences, the term "low" meaning that the alkyl groups in the radicals concerned contain 1-4 carbon atoms, are prepared (1) by reacting a g - or d -ketocarboxylic acid or derivative thereof of formula X-OC-A-CO-R in which X is a hydroxy, low alkoxy or alkanoyloxy group, or a chlorine or bromine atom, or the tautomeric form thereof, with an amine of formula H2N-B-OH, or (2) by subjecting a compound of formula HO-B-NH-OC-A-CO-R or the tautomeric form thereof, to conditions which split off water. Therapeutic compositions useful as antiinflammatory, anaesthesia-potentiating, anticonvulsive, and analgetic agents, and which may be administered orally, rectally or parenterally, contain as active ingredient compounds of Formula I above. |
